Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • SKINNER SR
    • DA SILVA DP
    • KITCHENER H
    • FONG KL
    • BOUCHARD C
    • MONEY DM
    • ILANCHERAN A
    • CRUICKSHANK ME
    • LEVIN MJ
    • CHATTERJEE A
    • STAPLETON JT
    • SZAREWSKI A
    • MARTENS M
    • QUINT W
    • DAVID M-P
    • MERIC D
    • HARDT K
    • DESCAMPS D
    • GEERAERTS B
    • STRUYF F
    • DUBIN G
    • ROMANOWSKI B
    • PROF Suzanne Garland Wark
    • LAZCANO-PONCE E
    • SALMERON J
    • ROWENA DEL ROSARIO-RAYMUNDO M
    • VERHEIJEN RHM
    • QUEK SC

Published in

  • The Lancet

Time

Date/time value

  • 2014

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(14)60920-X

Additional Document Info

Parent Title

  • LANCET

Volume

  • 384

Issue

  • 9961

Publisher

  • Lancet